Trial Profile
Effect of nivolumab monotherapy in patients with previously treated advanced non-small cell lung cancer (NSCLC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Jun 2016 New trial record